Daiwa Securities Group’s BioAtla BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4
Closed 1332
2023
Q3
$0 Hold
4
﹤0.01% 1294
2023
Q2
$1K Hold
4
﹤0.01% 1260
2023
Q1
$0 Hold
4
﹤0.01% 1302
2022
Q4
$2K Buy
4
+2
+100% +$830 ﹤0.01% 1214
2022
Q3
$1K Hold
2
﹤0.01% 1274
2022
Q2
$0 Hold
2
﹤0.01% 1361
2022
Q1
$1K Hold
2
﹤0.01% 1295
2021
Q4
$2K Buy
+2
New +$2.56K ﹤0.01% 1274

Other funds holding BCAB

Daiwa Securities Group's BCAB Position: Q4 2023 in Review

Daiwa Securities Group sold out of BioAtla (BCAB) in Q4 2023, closing a stake of 4 shares.

Daiwa Securities Group first reported a position in BCAB in Q4 2021 and held it in 8 quarters. The position peaked at $2K in Q4 2022. 79 funds tracked by Wall St. Rank hold BCAB as of Q4 2023.

  • Daiwa Securities Group reported no remaining BioAtla position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 4 BioAtla shares in Q4 2023.
  • Daiwa Securities Group first reported a position in BioAtla in Q4 2021 and held it in 8 quarters.
  • Daiwa Securities Group's BioAtla position peaked at $2K in Q4 2022.
  • 79 funds tracked by Wall St. Rank held BioAtla as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.